Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Neuroprotection of The Optic Nerve and The Retina

  • Protocol
  • First Online:
The Handbook of Neuroprotection

Part of the book series: Springer Protocols Handbooks ((SPH))

  • 842 Accesses

Abstract

The optic nerve and the retina are extensions of the CNS. A variety of disease processes such as toxic, inflammatory, ischemic and degenerative affect the optic nerve and can lead to blindness. Neuroprotective approaches have been explored to prevent damage to the optic nerve from acquired causes rather than genetic disorders with impairment of vision due to abnormalities such as optic nerve hypoplasia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Amadio M, Pascale A, Cupri S, et al. Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat. Pharmacol Res 2016;111:713–720.

    Article  CAS  Google Scholar 

  • Binley K, Widdowson PS, Kelleher M, et al. Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat®, for age-related macular degeneration. Hum Gene Ther 2012;23:980–91.

    Article  CAS  Google Scholar 

  • Butler F, Murphy-Lavoie H, Jain KK. In Jain KK: Textbook of Hyperbaric Medicine. 6th edition, Springer, New York, 2017.

    Google Scholar 

  • CATT Research Group. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med 2011; 364:1897–1908.

    Article  Google Scholar 

  • Collier RJ, Patel Y, Martin EA, et al. Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress. Invest Ophthalmol Vis Sci 2011;52:2118–26.

    Article  CAS  Google Scholar 

  • da Cruz L, Fynes K, Georgiadis O, et al. Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotech 2018;36:328–337.

    Article  Google Scholar 

  • Doonan F, Cotter TG. Norgestrel may be a potential therapy for retinal degenerations. Expert Opin Investig Drugs 2012;21:579–81.

    Article  CAS  Google Scholar 

  • Doonan F, O’Driscoll C, Kenna P, Cotter TG. Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel. J Neurochem 2011;118:915–27.

    Article  CAS  Google Scholar 

  • Ehrenberg M, Benny O. Evolving multidimensional pharmacological approaches to CNV therapy in AMD. Curr Eye Res 2018;43:147–154.

    Article  CAS  Google Scholar 

  • Fonseca-Kelly Z, Nassrallah M, Uribe J, et al. Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol 2012;3:84.

    Article  Google Scholar 

  • Guo X, Namekata K, Kimura A, et al. Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis. Neurosci Lett 2015;592:27–31.

    Article  CAS  Google Scholar 

  • Henderson AP, Altmann DR, Trip AS, et al. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 2010;133:2592–602.

    Article  Google Scholar 

  • Hoffmann DB, Williams SK, Bojcevski J, et al. Calcium influx and calpain activation mediate preclinical retinal neurodegeneration in autoimmune optic neuritis. J Neuropathol Exp Neurol 2013;72:745–57.

    Article  CAS  Google Scholar 

  • Jaffe GJ, Schmitz-Valckenberg S, Boyer D, et al. Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study. Am J Ophthalmol 2015;160:1226–34.

    Article  CAS  Google Scholar 

  • Kashani AH, Lebkowski JS, Rahhal FM, et al. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Science Translational Medicine 2019;10(435): eaao4097.

    Article  Google Scholar 

  • Klein R, Chou CF, Klein BE, et al. Prevalence of Age-Related Macular Degeneration in the US Population. Arch Ophthalmol 2011;129:75–80.

    Article  Google Scholar 

  • Klein R, Myers CE, Klein BE. Vasodilators, blood pressure-lowering medications, and age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2014 121:1604–11.

    Article  Google Scholar 

  • Kleinman ME, Yamada K, Takeda A, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008;452:591–7.

    Article  CAS  Google Scholar 

  • Lambiase A, Aloe L, Centofantic M, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. PNAS 2009;106:13469–74.

    Article  CAS  Google Scholar 

  • Lee D, Kim KY, Noh YH, et al. Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury. PLoS One 2012;7(10):e47098.

    Article  CAS  Google Scholar 

  • Lidster K, Jackson SJ, Ahmed Z, et al. Neuroprotection in a novel mouse model of multiple sclerosis. PLoS One 2013;8:e79188.

    Article  CAS  Google Scholar 

  • Lyttle DP, Johnson LN, Margolin EA, Madsen RW. Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2016;254:757–64.

    Article  CAS  Google Scholar 

  • Mandai M, Watanabe A, Kurimoto Y, et al. Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med 2017;376:1038–46.

    Article  CAS  Google Scholar 

  • Raftopoulos R, Hickman SJ, Toosy A, et al. Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 2016;15:259–69.

    Article  CAS  Google Scholar 

  • Sättler MB, Williams SK, Neusch C, et al. Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis. Am J Pathol 2008;173:1496–507.

    Article  Google Scholar 

  • Schwartz SD, Regillo CD, Lam BL, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 2015;385:509–16.

    Article  Google Scholar 

  • Sears JE, Hoppe G, Ebrahem Q, et al. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy. PNAS 2008;105:19898–903.

    Article  CAS  Google Scholar 

  • Sena DF, Ramchand K, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev 2010;2:CD006539.

    Google Scholar 

  • Sene A, Khan AA, Cox D, et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metabolism 2013;17:549–61.

    Article  CAS  Google Scholar 

  • Shen J, Ghai K, Sompol P, et al. N-acetyl serotonin derivatives as potent neuroprotectants for retinas. Proc Natl Acad Sci U S A 2012;109:3540–5.

    Article  CAS  Google Scholar 

  • Shindler KS, Ventura E, Dutt M, et al. Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol 2010;30:328–39.

    Article  Google Scholar 

  • Shirai H, Mandai M, Matsushita K, et al. Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration. Proc Natl Acad Sci U S A 2016;113:E81–90.Sühs et al 2014

    Article  CAS  Google Scholar 

  • Sur A, Kesaraju S, Prentice H, et al. Pharmacological protection of retinal pigmented epithelial cells by sulindac involves PPAR-α. Proc Natl Acad Sci U S A 2014;111:16754–9.

    Article  CAS  Google Scholar 

  • Wiley LA, Burnight ER, Songstad AE, et al. Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases. Prog Retin Eye Res 2015;44:15–35.

    Article  Google Scholar 

  • Wykoff CC, Clark WL, Nielsen JS, et al. Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration. J Manag Care Spec Pharm 2018;24(2-a Suppl):S3-S15.

    PubMed  Google Scholar 

  • Zhang K, Hopkins JJ, Heier JS, et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. PNAS 2011;108:6241–5.

    Article  CAS  Google Scholar 

  • Zheng A, Li Y, Tsang SH. Personalized therapeutic strategies for patients with retinitis pigmentosa. Expert Opin Biol Ther 2015;15:391–402.

    Article  Google Scholar 

  • Zuo L, Khan RS, Lee V, et al. SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest Ophthalmol Vis Sci 2013;54:5097–102.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jain PharmaBiotech, Basel, Switzerland

    Kewal K. Jain

Authors
  1. Kewal K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Jain, K.K. (2019). Neuroprotection of The Optic Nerve and The Retina. In: The Handbook of Neuroprotection. Springer Protocols Handbooks. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9465-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9465-6_12

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9464-9

  • Online ISBN: 978-1-4939-9465-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation